LifeTech Scientific Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	782.61	665.76	979.31	833.79	1,119	971.68
Short-Term Investments	171.37	205.13	80	-	158.11	170.99
Trading Asset Securities	441	311	120	-	199	-
Cash & Short-Term Investments	1,395	1,182	1,179	833.79	1,476	1,143
Cash Growth	33.94%	0.22%	41.44%	-43.52%	29.20%	227.39%
Accounts Receivable	205.21	136.69	105.19	137.09	110.04	107.14
Other Receivables	88.83	95.42	78.62	78.45	51.92	37.59
Receivables	294.04	232.11	183.81	215.54	161.96	144.73
Inventory	493.56	532.4	483.61	241.41	129.29	99.62
Other Current Assets	390.71	387.78	384.42	105.92	69.45	157.82
Total Current Assets	2,573	2,334	2,231	1,397	1,837	1,545
Property, Plant & Equipment	974.95	976.5	884.86	783.39	724.07	483.52
Long-Term Investments	595.55	421.94	531.71	725.5	48.63	421.03
Other Intangible Assets	763.32	70.25	75.15	84.42	76.07	35.48
Long-Term Deferred Tax Assets	118.05	117.14	83.03	62.6	47	35.9
Long-Term Deferred Charges	-	660.41	581.52	357.99	288.76	269.42
Other Long-Term Assets	308.53	319.96	308.95	279.56	162.12	164.36
Total Assets	5,334	4,900	4,696	3,690	3,184	2,955
Accounts Payable	557.37	59.54	124.09	62.65	30.76	18.71
Accrued Expenses	283.9	283.67	284.58	290.88	237.14	143.51
Current Portion of Long-Term Debt	-	-	-	-	-	174.46
Current Portion of Leases	3.06	3.79	6.29	5.04	11.05	6.85
Current Income Taxes Payable	53.42	32.2	45.94	37.82	34.03	33.03
Current Unearned Revenue	95.52	26.09	12.5	13.17	11.43	19.35
Other Current Liabilities	-	410.34	296.74	175.18	157.51	97.68
Total Current Liabilities	993.26	815.64	770.14	584.74	481.91	493.6
Long-Term Leases	0.85	1.19	3	4.64	4.63	4.67
Long-Term Unearned Revenue	44.3	49.79	40.93	37.17	32.08	30.29
Other Long-Term Liabilities	558.33	558.33	558.33	142.5	135	67.5
Total Liabilities	1,597	1,425	1,372	769.05	653.61	596.06
Common Stock	0.04	0.04	0.04	0.04	0.04	0.04
Additional Paid-In Capital	-	1,632	1,643	1,628	1,621	1,608
Retained Earnings	-	1,925	1,702	1,439	1,114	821.4
Comprehensive Income & Other	3,770	-62.85	24.94	-166.88	-231.38	-89.24
Total Common Equity	3,770	3,495	3,370	2,900	2,504	2,340
Minority Interest	-33.25	-19.08	-46.27	20.61	26.52	18.35
Shareholders' Equity	3,737	3,475	3,324	2,921	2,530	2,358
Total Liabilities & Equity	5,334	4,900	4,696	3,690	3,184	2,955
Total Debt	3.91	4.98	9.3	9.67	15.67	185.98
Net Cash (Debt)	1,391	1,177	1,170	824.12	1,461	956.69
Net Cash Growth	48.45%	0.59%	41.97%	-43.58%	52.68%	-
Net Cash Per Share	0.32	0.27	0.26	0.19	0.32	0.22
Filing Date Shares Outstanding	4,632	4,631	4,630	4,630	4,630	4,627
Total Common Shares Outstanding	4,632	4,631	4,630	4,630	4,630	4,627
Working Capital	1,580	1,519	1,461	811.92	1,355	1,051
Book Value Per Share	0.81	0.75	0.73	0.63	0.54	0.51
Tangible Book Value	3,007	3,424	3,295	2,816	2,428	2,305
Tangible Book Value Per Share	0.65	0.74	0.71	0.61	0.52	0.50
Buildings	-	708.42	641.54	560.72	198.81	198.07
Machinery	-	337.97	306.4	262.72	265.59	254.53
Construction In Progress	-	122.79	76.04	55.31	325.06	65.83
Leasehold Improvements	-	33.62	30.57	28.61	20.44	23.17

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.